187 related articles for article (PubMed ID: 8672984)
1. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents.
Greenwald P; Kelloff GJ; Boone CW; McDonald SS
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):691-702. PubMed ID: 8672984
[TBL] [Abstract][Full Text] [Related]
2. Biological consequences of the genetic changes which occur during human colorectal carcinogenesis.
Williams AC; Browne SJ; Manning AM; Hague A; van der Stappen JW; Paraskeva C
Semin Cancer Biol; 1993 Jun; 4(3):153-9. PubMed ID: 8318691
[TBL] [Abstract][Full Text] [Related]
3. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
6. Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia.
Karakosta A; Golias Ch; Charalabopoulos A; Peschos D; Batistatou A; Charalabopoulos K
J Exp Clin Cancer Res; 2005 Dec; 24(4):505-14. PubMed ID: 16471312
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic considerations in the evaluation of chemopreventive data.
Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet RA; Greenwald P; Hawk ET; Fay JR; Sigman CC
IARC Sci Publ; 1996; (139):203-19. PubMed ID: 8923032
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of colorectal cancer.
Gwyn K; Sinicrope FA
Am J Gastroenterol; 2002 Jan; 97(1):13-21. PubMed ID: 11808936
[TBL] [Abstract][Full Text] [Related]
9. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].
Couturier D
Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848
[TBL] [Abstract][Full Text] [Related]
10. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.
Jalving M; Koornstra JJ; De Jong S; De Vries EG; Kleibeuker JH
Aliment Pharmacol Ther; 2005 Feb; 21(4):321-39. PubMed ID: 15709983
[TBL] [Abstract][Full Text] [Related]
11. New rodent models for studies of chemopreventive agents.
Lipkin M
J Cell Biochem Suppl; 1997; 28-29():144-7. PubMed ID: 9589360
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.
Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI
Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310
[TBL] [Abstract][Full Text] [Related]
13. The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia.
Rigas B
Curr Opin Gastroenterol; 2007 Jan; 23(1):55-9. PubMed ID: 17133086
[TBL] [Abstract][Full Text] [Related]
14. Nutritional factors and polyamine metabolism in colorectal cancer.
Linsalata M; Russo F
Nutrition; 2008 Apr; 24(4):382-9. PubMed ID: 18262757
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers in colorectal cancer.
Owen RW
IARC Sci Publ; 2001; 154():101-11. PubMed ID: 11220650
[TBL] [Abstract][Full Text] [Related]
17. An overview of apoptosis and the prevention of colorectal cancer.
Watson AJ
Crit Rev Oncol Hematol; 2006 Feb; 57(2):107-21. PubMed ID: 16326109
[TBL] [Abstract][Full Text] [Related]
18. Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research.
Fenton JI; Hord NG
Carcinogenesis; 2006 May; 27(5):893-902. PubMed ID: 16474168
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker.
Mori H; Yamada Y; Hirose Y; Kuno T; Katayama M; Sakata K; Yoshida K; Sugie S; Hara A; Yoshimi N
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S71-5. PubMed ID: 12570338
[TBL] [Abstract][Full Text] [Related]
20. Polymeric black tea polyphenols inhibit 1,2-dimethylhydrazine induced colorectal carcinogenesis by inhibiting cell proliferation via Wnt/beta-catenin pathway.
Patel R; Ingle A; Maru GB
Toxicol Appl Pharmacol; 2008 Feb; 227(1):136-46. PubMed ID: 18037152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
